Qiu H, Hu X, Gao L, Chen L, Chen J, Yuan J, et al. Interleukin 10 enhanced CD8+ T cell activity and reduced CD8+ T cell apoptosis in patients with diffuse large B cell lymphoma. Exp Cell Res. 2017;360:146-152 pubmed publisher

Tang J, Zha J, Guo X, Shi P, Xu B. CXCR5+CD8+ T cells present elevated capacity in mediating cytotoxicity toward autologous tumor cells through interleukin 10 in diffuse large B-cell lymphoma. Int Immunopharmacol. 2017;50:146-151 pubmed publisher

Ma Q, Huang D, Zhang H, Wang S, Chen X. Exposure to particulate matter 2.5 (PM2.5) induced macrophage-dependent inflammation, characterized by increased Th1/Th17 cytokine secretion and cytotoxicity. Int Immunopharmacol. 2017;50:139-145 pubmed publisher

Herth I, Witzens Harig M, Beckhove P, Hose D, Meissner T, Neuber B, et al. Thalidomide maintenance therapy maturates the T cell compartment and compromises antigen-specific antitumor immunity in patients with multiple myeloma. Exp Hematol. 2013;41:231-40 pubmed publisher